UNIV TEXAS MD ANDERSON CANC CTR’s most-cited article reveals oncogenic KRAS-mediated reprogramming of glutamine metabolism in pancreatic cancer (34). The gene discussed is KRAS; the disease is pancreatic neoplasm.